Australia markets open in 4 hours 31 minutes
  • ALL ORDS

    7,282.10
    -45.90 (-0.63%)
     
  • AUD/USD

    0.7724
    -0.0034 (-0.43%)
     
  • ASX 200

    7,017.80
    -47.80 (-0.68%)
     
  • OIL

    62.61
    -0.77 (-1.21%)
     
  • GOLD

    1,778.00
    +7.40 (+0.42%)
     
  • BTC-AUD

    73,166.95
    +622.76 (+0.86%)
     
  • CMC Crypto 200

    1,285.48
    +51.07 (+4.14%)
     

$1.87 Billion Glycomics Market - Global Forecasts to 2025: Glycomes, Genetics, Physiological, Pathological - ResearchAndMarkets.com

·4-min read

The "Glycomics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

The glycomics market is evaluated at US$929.847 million for the year 2019 growing at a CAGR of 12.39% reaching the market size of US$1,874.247 million by the year 2025.

Glycomics is the comprehensive study of glycomes, including genetic, physiologic, pathologic, and other aspects. It refers to the study of all the glycan structures of a given cell type or organism in a systematic manner. The global glycomics market is anticipated to propel at a noteworthy CAGR that is primarily attributable to the fact that the growing research activities in glycomics in many parts of the world.

Additionally, the booming investments by pharmaceutical companies in the research and development activities also play a significant role in shaping up the market growth over the forecast period. Moreover, increased government support for the R&D in drug discovery and development coupled with the growth in the proteomics research studies will bolster the demand for glycomics products in the near future, thus positively impacting the growth over the next five years.

Additionally, the governments around the globe, and particularly in the developing economies are further enabling academic researchers to expand their knowledge in the field and develop new tools and products with an aim to promote the field of glycoscience. This, in turn, augments the business growth opportunities for the market players in the near future.

The outbreak of the novel coronavirus disease is anticipated to have a significant impact on market growth since companies are thriving hard to address the outbreak of this disease. Companies are expanding their R&D budgets and are working round the clock since the demand for commonly used drugs is significantly high in many countries. This, in turn, is boosting the pharmaceutical and biotechnology industry since the duration of this outbreak is still uncertain.

Key Developments in the market:

There is a significant volume of companies working in the glycomics market; however, some have solidified their position as the leading providers in this industry. These players are involved in a plethora of investments, product launches, and R&D as a part of their growth strategies to further strengthen their position and provide better products and services to their customers worldwide, which is further expected to propel the growth of the market in the coming years.

Key Topics Covered:

1. Introduction

1.1. Market Definition

1.2. Market Segmentation

2. Research Methodology

2.1. Research Data

2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.4. Industry Value Chain Analysis

5. Glycomics Market Analysis, by Product

5.1. Introduction

5.2. Enzymes

5.3. Instruments

5.4. Kits

5.5. Others

6. Glycomics Market Analysis, by Application

6.1. Introduction

6.2. Drug Discovery

6.3. Diagnostics

6.4. Others

7. Glycomics Market Analysis, by Geography

7.1. Introduction

7.2. North America

7.2.1. USA

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. Germany

7.4.2. France

7.4.3. UK

7.4.4. Others

7.5. Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Others

7.6. Asia Pacific

7.6.1. China

7.6.2. India

7.6.3. Japan

7.6.4. South Korea

7.6.5. Others

8. Competitive Environment and Analysis

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. Company Profiles

9.1. Merck KGaA

9.2. Thermo Fisher Scientific Inc.

9.3. Takara Bio Inc.

9.4. Shimadzu Corporation

9.5. Agilent Technologies, Inc.

9.6. Bruker

9.7. New England Biolabs

9.8. Asparia Glycomics

9.9. Z Biotech, LLC.

9.10. QA-Bio

9.11. AB SCIEX, LLC

For more information about this report visit https://www.researchandmarkets.com/r/4yw7fu

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005570/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900